GENTEX CORP
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.3B | $2.3B | $1.9B | $1.7B |
| Gross profit | $866.7M | $771.1M | $762.6M | $609.8M | $619.7M |
| Operating income | $473.9M | $459.7M | $495.7M | $370.0M | $409.8M |
| Operating expenses | $392.8M | $311.4M | $266.9M | $239.8M | $209.9M |
| Cost of revenue | $1.7B | $1.5B | $1.5B | $1.3B | $1.1B |
| Cash from operations | $587.1M | $498.2M | $537.2M | $338.2M | $362.2M |
| Capital expenditure | $129.1M | $144.7M | $183.7M | $146.4M | $68.8M |
| Free cash flow | $458.0M | $353.5M | $353.6M | $191.8M | $293.3M |
| Share repurchases | $315.5M | $206.1M | $147.4M | $112.5M | $324.6M |
| Impairments | $0 | $8.9M | $0 | $0 | $0 |
| Total assets | $2.9B | $2.8B | $2.6B | $2.3B | $2.1B |
| Total liabilities | $437.7M | $288.7M | $298.9M | $261.4M | $193.4M |
Shares outstanding 213.0M · Free float 96.6%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.